Anton Lesaca focuses his practice on regulatory matters involving the US Food and Drug Administration (FDA) and other regulatory authorities at the federal and state level.
Before joining Latham, Anton served as Associate Chief Counsel in the Office of the Chief Counsel at FDA where he principally advised the Center for Devices and Radiological Health (CDRH) on the development and implementation of regulatory policies, guidance documents, rulemaking, legislative efforts, and advisory actions related to medical devices. He also served as counsel of record for FDA in several tobacco civil money penalty cases before the Department of Health and Human Services Departmental Appeals Board. During his tenure in public service and in recognition of his efforts advising FDA on several novel and complex legal matters, he received the FDA Office of the Commissioner’s Outstanding Service Award, CDRH Visionary Recognition Award, and a Commissioner’s Special Citation.
Previously, Anton also worked as a regulatory associate at a large law firm counseling emerging and middle-market companies on FDA, Federal Trade Commission, Consumer Product Safety Commission, Environmental Protection Agency, and state regulatory agency matters.